Health Innovators - Steve Damon
Steven Damon, Micron Biomedical, BIO 2024, microneedles,
Newsletters and Deep Dive digital magazine
Steven Damon, Micron Biomedical, BIO 2024, microneedles,
ASCO 2024 marked the 10th anniversary of checkpoint inhibitors, which powerfully changed the nature of cancer immunotherapy.
During the 10th anniversary of the Veeva R&D and Quality Summit, held in Madrid in June, web editor Nicole Raleigh sat down with Chris Moore, president of Europe for Veeva Systems, to d
ASCO isn’t just a show for top 10 pharmas and Phase 3 readouts; it’s also a conference where smaller biopharmas share encouraging early-stage results, especially those that point to a new p
While advances in cell and gene therapies chip away at the need for bone marrow transplants, the transplantation field remains very much alive and in the midst of innovations of its own.
Editor's Picks
Newsletters and Deep Dive
digital magazine